This site is intended for healthcare professionals
News

Pivotal trial of OMS 721 shows good response rate in hematopoietic stem cell transplant-associated thrombotic microangiopathy.- Omeros Corp

Read time: 1 mins
Last updated:15th Jun 2020
Published:13th Jun 2020
Condition: Thrombotic Microangiopathies /HSCT- TMA
Type: drug
Register free for full access to medthority.com